Webinar/Video Archives - CMSC Scholar

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Target Audience The intended audience for this activity is neurologists, neurology nursing professionals, pharmacists, physician assistants, and other health care professionals involved in the management …

Continue reading “Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis”

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Released: January 11, 2021 Expires: January 11, 2022 Program Description This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and …

Continue reading “Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management”

Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care

Released: November 13, 2020 Expires: November 13, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by an independent education grant from Sanofi Genzyme. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — 1.0 Nursing Contact Hours Pharmacists — 1.0 Contact Hours (.1 CEUs) All other …

Continue reading “Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care”

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS RELEASE DATE: October 20, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis”

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES RELEASE DATE: October 27, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies”

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES RELEASE DATE: NOVEMEBER 11, 2020 VALID FOR CREDIT THROUGH: OCTOBER 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies”

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited by the Consortium of Multiple Sclerosis Centers (CMSC) and Haymarket Medical Education (HME). Supported by an educational grant from Bristol Myers Squibb. Intended Audience Neurologists and other physicians, nurse practitioners, PAs, registered nurses, and pharmacists who collaborate to provide care for patients with MS Program …

Continue reading “Next-Generation S1P Modulators in MS Management”

Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October 21, 2021 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and CMEology. This activity is supported by educational grants from Biogen, Bristol Myers Squibb, and EMD Serono. Target Audience This activity is designed to meet the educational needs of neurologists, …

Continue reading “Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis”

Differing Perspectives on Multiple Sclerosis Nursing Care

Release Date: October 20, 2020 Valid for Credit Through: October 31, 2021 Target Audience The target audience for this activity is nursing professionals involved in the management of patients with MS. Learning Objectives At the conclusion of this activity, learners should be better able to: Incorporate accumulated evidence, current guidelines, and emerging new clinical data …

Continue reading “Differing Perspectives on Multiple Sclerosis Nursing Care”

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

Release Date: July 31, 2020 Valid for Credit Through: July 31, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported in part by independent education grants from Alexion Pharmaceuticals and Genentech. Credit Available Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™ Nurses — 1.25 Nursing Contact Hours Pharmacists — 1.25 Contact …

Continue reading “The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment”